Australia will become the first country in the world to recognise MDMA, the active ingredient in the party drug ecstacy, as a medicine for post traumatic stress disorder.
From July 1, the Therapeutic Goods Administration will permit specifically-authorised psychiatrists to prescribe MDMA, otherwise known as methlyenedioxymethamphetamine, for PTSD and psilocybin, the active ingredient in psychedelic mushrooms, for treatment-resistant depression.
